基本说明会：

 David Cho, Ph.D., M.P.H., Senior Scientist for Emerging
 and PandemicThreat Preparedness, Office of the Director,
 Center for Biologics Evaluation and Research (CBER), FDA

 Norman Baylor, Ph.D., Director, Office of Vaccines Research
 and Review (OVRR), Center forBiologics Evaluation and
 Research (CBER), Food and Drug Administration, FDA

 Jay Berzofsky, M.D., Ph.D., Chief, Vaccine Branch, Center
 for Cancer Research, National Cancer Institute (NCI),
 National Institutes of Health

 George Siber, Ph.D., Director, Selecta Biosciences, and
 Executive Chairman, Genocea Biosciences

活动强调重点：

短期课程：
8月16日（星期一）

  SC1 疫苗商业的市场机会:
  协同合作和M&A 

  SC2 疫苗制造的单次使用（抛弃式）
系统